ID   MEL-CLS-2
AC   CVCL_6001
DR   cancercelllines; CVCL_6001
DR   CLS; 300283
DR   Wikidata; Q54905084
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft (CLS=300283).
CC   HLA typing: A*02:06:01,20:02:01; B*39:01:01,53:01:01; C*03:04:01,04:01:01; DPB1*02:01,04:01; DQA1*03:03:01,05:01:01; DQB1*02:01:01,03:01:01; DRB1*03:01:01,04:01:01 (CLS=300283).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CLS=300283).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): CLS=300283
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 7,11
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//